1. Home
  2. PEPG vs AHG Comparison

PEPG vs AHG Comparison

Compare PEPG & AHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PEPG
  • AHG
  • Stock Information
  • Founded
  • PEPG 2018
  • AHG 2013
  • Country
  • PEPG United States
  • AHG China
  • Employees
  • PEPG N/A
  • AHG N/A
  • Industry
  • PEPG Biotechnology: Pharmaceutical Preparations
  • AHG Business Services
  • Sector
  • PEPG Health Care
  • AHG Consumer Discretionary
  • Exchange
  • PEPG Nasdaq
  • AHG Nasdaq
  • Market Cap
  • PEPG 250.3M
  • AHG 245.7M
  • IPO Year
  • PEPG 2022
  • AHG N/A
  • Fundamental
  • Price
  • PEPG $4.32
  • AHG $0.88
  • Analyst Decision
  • PEPG Buy
  • AHG
  • Analyst Count
  • PEPG 3
  • AHG 0
  • Target Price
  • PEPG $14.67
  • AHG N/A
  • AVG Volume (30 Days)
  • PEPG 133.3K
  • AHG 19.8K
  • Earning Date
  • PEPG 11-07-2024
  • AHG 11-29-2024
  • Dividend Yield
  • PEPG N/A
  • AHG N/A
  • EPS Growth
  • PEPG N/A
  • AHG N/A
  • EPS
  • PEPG N/A
  • AHG N/A
  • Revenue
  • PEPG N/A
  • AHG $2,414,338.00
  • Revenue This Year
  • PEPG N/A
  • AHG N/A
  • Revenue Next Year
  • PEPG N/A
  • AHG N/A
  • P/E Ratio
  • PEPG N/A
  • AHG N/A
  • Revenue Growth
  • PEPG N/A
  • AHG N/A
  • 52 Week Low
  • PEPG $4.00
  • AHG $0.53
  • 52 Week High
  • PEPG $19.30
  • AHG $2.90
  • Technical
  • Relative Strength Index (RSI)
  • PEPG 23.52
  • AHG 47.13
  • Support Level
  • PEPG $4.00
  • AHG $0.86
  • Resistance Level
  • PEPG $4.77
  • AHG $0.94
  • Average True Range (ATR)
  • PEPG 0.56
  • AHG 0.11
  • MACD
  • PEPG -0.05
  • AHG 0.00
  • Stochastic Oscillator
  • PEPG 9.14
  • AHG 29.78

About PEPG PepGen Inc.

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.

About AHG Akso Health Group ADS

Akso Health Group formerly Xiaobai Maimai Inc is a social e-commerce platform based in China. The company collaborates with domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products on its social e-commerce platform. It generates majority of the revenues from sale of medical devices business.

Share on Social Networks: